Centre de Recherche Saint-Louis

Sherbrooke, Quebec J1G 1X9

1 studies enrolling now · 3 studies all time

What they study most

Active Nonsegmental Vitiligo, Alopecia Areata, Plaque Psoriasis, Stable Nonsegmental Vitiligo

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling